特征和六个月病毒载量抑制客户呈现晚期艾滋病病毒病在南非。

IF 2.5
PLOS global public health Pub Date : 2025-09-23 eCollection Date: 2025-01-01 DOI:10.1371/journal.pgph.0004927
Elizabeth Kachingwe, Nyasha Mutanda, Vinolia Ntjikelane, Mariet Benade, Musa Manganye, Lufuno Malala, Sydney Rosen, Mhairi Maskew
{"title":"特征和六个月病毒载量抑制客户呈现晚期艾滋病病毒病在南非。","authors":"Elizabeth Kachingwe, Nyasha Mutanda, Vinolia Ntjikelane, Mariet Benade, Musa Manganye, Lufuno Malala, Sydney Rosen, Mhairi Maskew","doi":"10.1371/journal.pgph.0004927","DOIUrl":null,"url":null,"abstract":"<p><p>Despite advances in antiretroviral therapy (ART), a notable proportion of individuals still present with advanced HIV disease (AHD) at treatment initiation, defined by CD4 < 200 cells/µL or WHO stage 3/4. This group experiences higher mortality and more opportunistic infections. While guidelines exist, they often do not address AHD clients specific needs early in treatment. Addressing these gaps could improve outcomes. Between September 2022 and June 2023, we surveyed a sequential sample of clients initiating ART or ≤6 months post-initiation at 18 primary healthcare facilities across three provinces. This observational cohort collected socio-demographic data, HIV care history, and service delivery preferences, and linked surveys to routine medical records and described client characteristics using descriptive statistics. Relative risks and risk differences compared outcomes between AHD and non-AHD clients. Primary outcomes were 6-month retention and viral load suppression. Of 1,098 clients (72% female, median age 33), 938 had CD4 or WHO staging at ART start. Of these, 29% (n = 275) had AHD, with a median CD4 of 108 cells/µL. AHD clients were more often male (44% vs. 21%), older (median age: 38 vs. 31 years), and sought care due to illness (63% vs. 33%). TB diagnosis (42% vs. 12%) and testing (76% vs. 67%) were higher. Service preferences and health resource use were similar. Retention at 6 months was similar (80% vs. 75%), but mortality was higher in AHD clients (1.0% vs. 0.2%). AHD clients had more low-level viremia (24% vs. 11%; RR = 2.27, 95% CI = 1.67-3.09) and slightly lower suppression (43% vs. 47%). AHD remains a key barrier to optimal ART outcomes. Clients with AHD experienced poorer viral suppression, despite similar retention rates highlighting the need for early detection, tailored clinical support, and strengthened monitoring. Updating ART guidelines to address AHD-specific needs is critical to improving outcomes in this high-risk population.</p>","PeriodicalId":74466,"journal":{"name":"PLOS global public health","volume":"5 9","pages":"e0004927"},"PeriodicalIF":2.5000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12456826/pdf/","citationCount":"0","resultStr":"{\"title\":\"Characteristics and six-month viral load suppression of clients presenting with advanced HIV disease in South Africa.\",\"authors\":\"Elizabeth Kachingwe, Nyasha Mutanda, Vinolia Ntjikelane, Mariet Benade, Musa Manganye, Lufuno Malala, Sydney Rosen, Mhairi Maskew\",\"doi\":\"10.1371/journal.pgph.0004927\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Despite advances in antiretroviral therapy (ART), a notable proportion of individuals still present with advanced HIV disease (AHD) at treatment initiation, defined by CD4 < 200 cells/µL or WHO stage 3/4. This group experiences higher mortality and more opportunistic infections. While guidelines exist, they often do not address AHD clients specific needs early in treatment. Addressing these gaps could improve outcomes. Between September 2022 and June 2023, we surveyed a sequential sample of clients initiating ART or ≤6 months post-initiation at 18 primary healthcare facilities across three provinces. This observational cohort collected socio-demographic data, HIV care history, and service delivery preferences, and linked surveys to routine medical records and described client characteristics using descriptive statistics. Relative risks and risk differences compared outcomes between AHD and non-AHD clients. Primary outcomes were 6-month retention and viral load suppression. Of 1,098 clients (72% female, median age 33), 938 had CD4 or WHO staging at ART start. Of these, 29% (n = 275) had AHD, with a median CD4 of 108 cells/µL. AHD clients were more often male (44% vs. 21%), older (median age: 38 vs. 31 years), and sought care due to illness (63% vs. 33%). TB diagnosis (42% vs. 12%) and testing (76% vs. 67%) were higher. Service preferences and health resource use were similar. Retention at 6 months was similar (80% vs. 75%), but mortality was higher in AHD clients (1.0% vs. 0.2%). AHD clients had more low-level viremia (24% vs. 11%; RR = 2.27, 95% CI = 1.67-3.09) and slightly lower suppression (43% vs. 47%). AHD remains a key barrier to optimal ART outcomes. Clients with AHD experienced poorer viral suppression, despite similar retention rates highlighting the need for early detection, tailored clinical support, and strengthened monitoring. Updating ART guidelines to address AHD-specific needs is critical to improving outcomes in this high-risk population.</p>\",\"PeriodicalId\":74466,\"journal\":{\"name\":\"PLOS global public health\",\"volume\":\"5 9\",\"pages\":\"e0004927\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12456826/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PLOS global public health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1371/journal.pgph.0004927\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLOS global public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1371/journal.pgph.0004927","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

尽管抗逆转录病毒疗法(ART)取得了进展,但在治疗开始时仍有相当大比例的个体呈现晚期艾滋病毒疾病(AHD),由CD4定义
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Characteristics and six-month viral load suppression of clients presenting with advanced HIV disease in South Africa.

Characteristics and six-month viral load suppression of clients presenting with advanced HIV disease in South Africa.

Characteristics and six-month viral load suppression of clients presenting with advanced HIV disease in South Africa.

Characteristics and six-month viral load suppression of clients presenting with advanced HIV disease in South Africa.

Despite advances in antiretroviral therapy (ART), a notable proportion of individuals still present with advanced HIV disease (AHD) at treatment initiation, defined by CD4 < 200 cells/µL or WHO stage 3/4. This group experiences higher mortality and more opportunistic infections. While guidelines exist, they often do not address AHD clients specific needs early in treatment. Addressing these gaps could improve outcomes. Between September 2022 and June 2023, we surveyed a sequential sample of clients initiating ART or ≤6 months post-initiation at 18 primary healthcare facilities across three provinces. This observational cohort collected socio-demographic data, HIV care history, and service delivery preferences, and linked surveys to routine medical records and described client characteristics using descriptive statistics. Relative risks and risk differences compared outcomes between AHD and non-AHD clients. Primary outcomes were 6-month retention and viral load suppression. Of 1,098 clients (72% female, median age 33), 938 had CD4 or WHO staging at ART start. Of these, 29% (n = 275) had AHD, with a median CD4 of 108 cells/µL. AHD clients were more often male (44% vs. 21%), older (median age: 38 vs. 31 years), and sought care due to illness (63% vs. 33%). TB diagnosis (42% vs. 12%) and testing (76% vs. 67%) were higher. Service preferences and health resource use were similar. Retention at 6 months was similar (80% vs. 75%), but mortality was higher in AHD clients (1.0% vs. 0.2%). AHD clients had more low-level viremia (24% vs. 11%; RR = 2.27, 95% CI = 1.67-3.09) and slightly lower suppression (43% vs. 47%). AHD remains a key barrier to optimal ART outcomes. Clients with AHD experienced poorer viral suppression, despite similar retention rates highlighting the need for early detection, tailored clinical support, and strengthened monitoring. Updating ART guidelines to address AHD-specific needs is critical to improving outcomes in this high-risk population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信